136 related articles for article (PubMed ID: 1454834)
1. Additional antitumor ecteinascidins from a Caribbean tunicate: crystal structures and activities in vivo.
Sakai R; Rinehart KL; Guan Y; Wang AH
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11456-60. PubMed ID: 1454834
[TBL] [Abstract][Full Text] [Related]
2. Molecular and crystal structures of ecteinascidins: potent antitumor compounds from the Caribbean tunicate Ecteinascidia turbinata.
Guan Y; Sakai R; Rinehart KL; Wang AH
J Biomol Struct Dyn; 1993 Apr; 10(5):793-818. PubMed ID: 8318161
[TBL] [Abstract][Full Text] [Related]
3. Advances in the chemistry and pharmacology of ecteinascidins, a promising new class of anti-cancer agents.
Manzanares I; Cuevas C; García-Nieto R; Marco E; Gago F
Curr Med Chem Anticancer Agents; 2001 Nov; 1(3):257-76. PubMed ID: 12678757
[TBL] [Abstract][Full Text] [Related]
4. Ecteinascidins 770 and 786 from the Thai tunicate Ecteinascidia thurstoni.
Suwanborirux K; Charupant K; Amnuoypol S; Pummangura S; Kubo A; Saito N
J Nat Prod; 2002 Jun; 65(6):935-7. PubMed ID: 12088444
[TBL] [Abstract][Full Text] [Related]
5. Antitumor compounds from tunicates.
Rinehart KL
Med Res Rev; 2000 Jan; 20(1):1-27. PubMed ID: 10608919
[TBL] [Abstract][Full Text] [Related]
6. The potent anticancer compound ecteinascidin-743 (ET-743) as its 2-propanol disolvate.
Sainz-Diaz CI; Manzanares I; Francesch A; Garcia-Ruiz J
Acta Crystallogr C; 2003 Apr; 59(Pt 4):O197-8. PubMed ID: 12682407
[TBL] [Abstract][Full Text] [Related]
7. Chemistry of ecteinascidins. Part 3: preparation of 2'-N-acyl derivatives of ecteinascidin 770 and evaluation of cytotoxicity.
Saktrakulkla P; Toriumi S; Tsujimoto M; Patarapanich C; Suwanborirux K; Saito N
Bioorg Med Chem; 2011 Aug; 19(15):4421-36. PubMed ID: 21752654
[TBL] [Abstract][Full Text] [Related]
8. DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata.
Pommier Y; Kohlhagen G; Bailly C; Waring M; Mazumder A; Kohn KW
Biochemistry; 1996 Oct; 35(41):13303-9. PubMed ID: 8873596
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.
Shimomura K; Manda T; Mukumoto S; Masuda K; Nakamura T; Mizota T; Matsumoto S; Nishigaki F; Oku T; Mori J
Cancer Res; 1988 Mar; 48(5):1166-72. PubMed ID: 3342397
[TBL] [Abstract][Full Text] [Related]
10. Chemistry of ecteinascidins. Part 2. Preparation of 6'-O-acyl derivatives of stable ecteinascidin and evaluation of cytotoxicity.
Puthongking P; Patarapanich C; Amnuoypol S; Suwanborirux K; Kubo A; Saito N
Chem Pharm Bull (Tokyo); 2006 Jul; 54(7):1010-6. PubMed ID: 16819221
[TBL] [Abstract][Full Text] [Related]
11. Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics.
Le VH; Inai M; Williams RM; Kan T
Nat Prod Rep; 2015 Feb; 32(2):328-47. PubMed ID: 25273374
[TBL] [Abstract][Full Text] [Related]
12. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
[TBL] [Abstract][Full Text] [Related]
13. FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome.
Naoe Y; Inami M; Matsumoto S; Nishigaki F; Tsujimoto S; Kawamura I; Miyayasu K; Manda T; Shimomura K
Cancer Chemother Pharmacol; 1998; 42(1):31-6. PubMed ID: 9619755
[TBL] [Abstract][Full Text] [Related]
14. Palmerolide A, a cytotoxic macrolide from the antarctic tunicate Synoicum adareanum.
Diyabalanage T; Amsler CD; McClintock JB; Baker BJ
J Am Chem Soc; 2006 May; 128(17):5630-1. PubMed ID: 16637618
[TBL] [Abstract][Full Text] [Related]
15. Chemistry of ecteinascidins. Part 4: preparation of 2'-N-acyl ecteinascidin 770 derivatives with improved cytotoxicity profiles.
Tsujimoto M; Lowtangkitcharoen W; Mori N; Pangkruang W; Putongking P; Suwanborirux K; Saito N
Chem Pharm Bull (Tokyo); 2013; 61(10):1052-64. PubMed ID: 24088697
[TBL] [Abstract][Full Text] [Related]
16. Eudistomidins H-K, new β-carboline alkaloids from the Okinawan marine tunicate Eudistoma glaucus.
Suzuki T; Kubota T; Kobayashi J
Bioorg Med Chem Lett; 2011 Jul; 21(14):4220-3. PubMed ID: 21684745
[TBL] [Abstract][Full Text] [Related]
17. ET-743 (PharmaMar/NCI/Ortho Biotech).
Verschraegen CF; Glover K
Curr Opin Investig Drugs; 2001 Nov; 2(11):1631-8. PubMed ID: 11763168
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
Fujimoto K; Oka T; Morimoto M
Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
[TBL] [Abstract][Full Text] [Related]
19. Absolute stereochemistry and antitumor activity of iejimalides.
Nozawa K; Tsuda M; Ishiyama H; Sasaki T; Tsuruo T; Kobayashi J
Bioorg Med Chem; 2006 Feb; 14(4):1063-7. PubMed ID: 16216511
[TBL] [Abstract][Full Text] [Related]
20. Development of Yondelis (trabectedin, ET-743). A semisynthetic process solves the supply problem.
Cuevas C; Francesch A
Nat Prod Rep; 2009 Mar; 26(3):322-37. PubMed ID: 19240944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]